U.S. Precision Genomic Testing Market Size & Outlook

Name: U.S. Precision Genomic Testing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The precision genomic testing market in the United States is expected to reach a projected revenue of US$ 9,641.4 million by 2030. A compound annual growth rate of 12.8% is expected of the United States precision genomic testing market from 2025 to 2030.

U.S. precision genomic testing product outlook (Revenue, USD million, 2018-2030)
- Consumables
  - Reagents
  - Kits
- Services
- Equipment
U.S. precision genomic testing technology outlook (Revenue, USD million, 2018-2030)
- Others
- Next-Generation Sequencing
- Microarray Technology
- Polymerase Chain Reaction
- Sanger Sequencing
- CRISPR/Cas Systems
U.S. precision genomic testing application outlook (Revenue, USD million, 2018-2030)
- Reproductive Health
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Oncology
- Others
U.S. precision genomic testing end use outlook (Revenue, USD million, 2018-2030)
- Others
- Diagnostic Laboratories
- Hospitals and Clinics
- Research & Academic Institutes

U.S. Precision Genomic Testing Market Size & Outlook

Sign up - it's easy, and free!